Medication Treatments for Opioid Use Disorder: What Is the Impact on Mood and Mood Disorders?

Medication Treatments for Opioid Use Disorder: What Is the Impact on Mood and Mood Disorders? Purpose of Review There has been an interest in evaluating the effect of opioid medications on mood in patients with or without opioid use disorder (OUD) because of potential mechanistic relationships between the opioid system and mood. In this review, we will summarize the prospective clinical trials that used opioid medications (naltrexone, methadone, and buprenorphine) to evaluate the effect on mood and anxiety in patients with and without OUD. Findings Buprenorphine and buprenorphine/samidorphan combination have shown promising short-term effect for depressed patients without OUD but the effects are modest. Naltrexone does not worsen mood in patients with OUD and is in fact associated with improved mood for adherent patients. Methadone and buprenorphine treatment for OUD are both associated with substantial improvements in mood. Implications Buprenorphine or buprenorphine combined with a mu receptor antagonist may be effective for treatment-resistant depression among patients without OUD, and large randomized controlled trials with longer trial lengths are needed to further evaluate this effect. Among patients with OUD, effective medication treatment for the OUD is the priority, and with any opioid medication mood often improves. . . . . . Keywords Opioid medication Opioid agonist therapy Opioid use disorder Depression Mood Anxiety Introduction treatment http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Addiction Reports Springer Journals

Medication Treatments for Opioid Use Disorder: What Is the Impact on Mood and Mood Disorders?

Loading next page...
 
/lp/springer_journal/medication-treatments-for-opioid-use-disorder-what-is-the-impact-on-YExTYZnOmk
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Psychiatry; Neurology
eISSN
2196-2952
D.O.I.
10.1007/s40429-018-0215-x
Publisher site
See Article on Publisher Site

Abstract

Purpose of Review There has been an interest in evaluating the effect of opioid medications on mood in patients with or without opioid use disorder (OUD) because of potential mechanistic relationships between the opioid system and mood. In this review, we will summarize the prospective clinical trials that used opioid medications (naltrexone, methadone, and buprenorphine) to evaluate the effect on mood and anxiety in patients with and without OUD. Findings Buprenorphine and buprenorphine/samidorphan combination have shown promising short-term effect for depressed patients without OUD but the effects are modest. Naltrexone does not worsen mood in patients with OUD and is in fact associated with improved mood for adherent patients. Methadone and buprenorphine treatment for OUD are both associated with substantial improvements in mood. Implications Buprenorphine or buprenorphine combined with a mu receptor antagonist may be effective for treatment-resistant depression among patients without OUD, and large randomized controlled trials with longer trial lengths are needed to further evaluate this effect. Among patients with OUD, effective medication treatment for the OUD is the priority, and with any opioid medication mood often improves. . . . . . Keywords Opioid medication Opioid agonist therapy Opioid use disorder Depression Mood Anxiety Introduction treatment

Journal

Current Addiction ReportsSpringer Journals

Published: Jun 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off